Aaron is Co-Founder and Chief Executive Officer of Boxer Capital, LLC. After joining Tavistock Group as Portfolio Manager, Aaron scaled Tavistock Group’s public healthcare investing activities and formed Boxer Capital. Aaron leads the firm’s research team, deal structuring and portfolio management.
Aaron is currently Chairman of the Board of CiVi Biopharma and member of the Board of Directors for iTeos Therapeutics (NASDAQ: ITOS), Mirati Therapeutics (NASDAQ: MRTX) and Odonate Therapeutics (NASDAQ: ODT).
Prior to joining Tavistock Group, Aaron worked in the Global Healthcare Investment Banking and Private Equity Group at UBS Warburg, LLC. During this period, Aaron led strategic transactions for public and private biotechnology and medical device companies throughout their growth, advising on financing and mergers and acquisitions. Having served in various roles with biotechnology and venture capital firms, Aaron has extensive expertise in investment analysis and overseeing in-licensing activities within the pharmaceutical sector.
Aaron holds a M.S. in Biotechnology from Columbia University and a B.A. in Business Administration from Emory University.